The laboratory, which was showcased at this year’s meeting of the American Society of Pharmaceutical Scientists (AAPS) in Atlanta, will provide analytical, testing and formulation development services to Azopharma’s European clients.
Phil Meeks, CEO of Azopharma’s Product Development Group, explained that the new laboratory is situated in the UK’s “golden triangle” between Cambridge, Oxford and London which is home to many of Europe’s leading pharmaceutical companies.
